Biventricular Cardiomyopathy Improvement by Shifting Therapy From Agalsidase Alfa to Agalsidase Beta in Anderson-Fabry Disease (RCD Code: III-3B.2)
Journal of Rare Cardiovascular Diseases - Poland
doi 10.20418/jrcd.vol3no6.315
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2018
Authors
Publisher
SoftQ Sp. z.o.o.